Global Whole Exome Sequencing Service Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Whole Exome Sequencing Service market size will reach US$ 5291 million by 2031.
Whole Exome Sequencing (WES) Service is a specialized high-throughput sequencing service focused on analyzing the exonic regions of the genome, which comprise the protein-coding portions accounting for approximately 1%–2% of the human genome. This service is widely used in genetic research, rare disease diagnostics, cancer mutation profiling, and precision medicine. By employing targeted capture and deep sequencing technologies, WES enables the comprehensive detection of genetic variants such as single nucleotide variants (SNVs) and small insertions/deletions (indels), offering a cost-effective yet information-rich approach. A standard WES service includes sample preparation, library construction, target enrichment, sequencing, quality control, variant calling, functional annotation, and clinical interpretation. Whole Exome Sequencing is a powerful tool for identifying disease-associated mutations, discovering novel genes, and guiding personalized treatment strategies, playing a crucial role in both medical genetics and translational research.
United States market for Whole Exome Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Whole Exome Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Whole Exome Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Whole Exome Sequencing Service players cover Novogene, Eurofins Scientific, CD Genomics, Signios Bio, Macrogen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Whole Exome Sequencing Service Industry Forecast” looks at past sales and reviews total world Whole Exome Sequencing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Whole Exome Sequencing Service sales for 2025 through 2031. With Whole Exome Sequencing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Whole Exome Sequencing Service industry.
This Insight Report provides a comprehensive analysis of the global Whole Exome Sequencing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Whole Exome Sequencing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Whole Exome Sequencing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Whole Exome Sequencing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Whole Exome Sequencing Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Whole Exome Sequencing Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Clinical Whole Exome Sequencing
Research Whole Exome Sequencing
Others
Segmentation by Application:
Hospitals
Biopharma Companies
Academic and Research Organizations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novogene
Eurofins Scientific
CD Genomics
Signios Bio
Macrogen
Roche
BGI
Psomagen
Centogene
Natera
Personalis
GENEWIZ
LabCorp
Brooks Life Sciences
Illumina
Berry Genomics
Please note: The report will take approximately 2 business days to prepare and deliver.
Whole Exome Sequencing (WES) Service is a specialized high-throughput sequencing service focused on analyzing the exonic regions of the genome, which comprise the protein-coding portions accounting for approximately 1%–2% of the human genome. This service is widely used in genetic research, rare disease diagnostics, cancer mutation profiling, and precision medicine. By employing targeted capture and deep sequencing technologies, WES enables the comprehensive detection of genetic variants such as single nucleotide variants (SNVs) and small insertions/deletions (indels), offering a cost-effective yet information-rich approach. A standard WES service includes sample preparation, library construction, target enrichment, sequencing, quality control, variant calling, functional annotation, and clinical interpretation. Whole Exome Sequencing is a powerful tool for identifying disease-associated mutations, discovering novel genes, and guiding personalized treatment strategies, playing a crucial role in both medical genetics and translational research.
United States market for Whole Exome Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Whole Exome Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Whole Exome Sequencing Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Whole Exome Sequencing Service players cover Novogene, Eurofins Scientific, CD Genomics, Signios Bio, Macrogen, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Whole Exome Sequencing Service Industry Forecast” looks at past sales and reviews total world Whole Exome Sequencing Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Whole Exome Sequencing Service sales for 2025 through 2031. With Whole Exome Sequencing Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Whole Exome Sequencing Service industry.
This Insight Report provides a comprehensive analysis of the global Whole Exome Sequencing Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Whole Exome Sequencing Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Whole Exome Sequencing Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Whole Exome Sequencing Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Whole Exome Sequencing Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Whole Exome Sequencing Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Clinical Whole Exome Sequencing
Research Whole Exome Sequencing
Others
Segmentation by Application:
Hospitals
Biopharma Companies
Academic and Research Organizations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novogene
Eurofins Scientific
CD Genomics
Signios Bio
Macrogen
Roche
BGI
Psomagen
Centogene
Natera
Personalis
GENEWIZ
LabCorp
Brooks Life Sciences
Illumina
Berry Genomics
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
121 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Whole Exome Sequencing Service Market Size by Player
- 4 Whole Exome Sequencing Service by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Whole Exome Sequencing Service Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
